From 1 September 2025 the eligibility criteria widened for access to COVID-19 antivirals.
The new addition to the eligibility criteria allows access for people who are 50 years and over and considered by their healthcare professional to be at high risk of severe outcomes from COVID-19 infection. Other access criteria remain the same.
Additional information about the criteria change and guidance to help identify patients who are at risk of severe illness with COVID-19 infection can be found on the Pharmac website.
BPAC has developed guidance to support health care professionals assess whether someone is at high risk of hospitalisation or death from COVID-19, this can be found on the BPAC website.
During the COVID-19 lockdown virtual consultations for POAC cases were funded. We are pleased to announce that this will be a permanent change.
Read moreIn the first 10 days of 2025 there were x3 pertussis cases in Tairawhiti, x5 cases in Taranaki, x5 cases in Lakes, x6 cases in Waikato, and x18 cases in the Bay of Plenty. Please continue to be on alert. View the key messages for GPs here.
Vaccination for people and whānau eligible for COVID-19 vaccination.
View details